The groundbreaking therapy of the medication represents a major breakthrough in the management of the condition. Unlike existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide222340.thelateblog.com/42364556/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment